Finance

Beta
Lists
MCRB:NASDAQ
Seres Therapeutics Inc
$7.94
+0.63%
(+0.050) 1D
$7.94
0.00% (0.00)
After hours
Closed: Jul 1, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MCRB...
Open
$7.82
High
$8.00
Low
$7.61
Mkt. cap
76.89M
Avg. vol.
87.29K
Volume
0.00
52-wk high
$29.98
52-wk low
$5.31
EPS
-$5.08
Beta
0.12
Shares outstanding
9.68M
No. of employees
66
Open
$7.82
High
$8.00
Low
$7.61
Mkt. cap
76.89M
Avg. vol.
87.29K
Volume
0.00
52-wk high
$29.98
52-wk low
$5.31
EPS
-$5.08
Beta
0.12
Shares outstanding
9.68M
No. of employees
66
News stories
From sources across the web
About Seres Therapeutics Inc
CEOEric Shaff
Employees66
Founded2010
Headquarters-
SectorBiotechnology
Websiteserestherapeutics.com
Analyst ratings
Based on 2 analysts giving stock ratings to MCRB in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for MCRB in the last 3 months.
Highest
Current $7.94
$22.00 (+177.08%)
Average
$17.00 (+114.11%)
Lowest
$12.00 (+51.13%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Keller
H.C. Wainwright
Buy
Initiated
$12.00
+51.1%
06/23/2026
John Newman
Canaccord Genuity
Buy
Maintained
$22.00
+177.1%
05/06/2026
Edward Tenthoff
Piper Sandler
Hold
Maintained
$20.00
+151.9%
02/13/2026
Joseph Thome
TD Cowen
Buy
Maintained
-
-
11/05/2025
Last report
May 5, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$2.08 / -$1.88
-10.64%miss
Revenue / Est. (USD)
358.00K / 0.00
+∞%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
351.00K
438.00K
358.00K
Cost of goods sold
14.63M
13.35M
12.28M
13.20M
Cost of revenue
14.63M
13.35M
12.28M
13.20M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.25M
9.48M
7.54M
8.07M
Operating expense
10.25M
9.48M
7.54M
8.07M
Total operating expenses
24.88M
22.83M
19.82M
21.26M
Operating income
-24.88M
-22.48M
-19.38M
-20.91M
Other non operating income
4.30M
2.84M
2.33M
669.00K
EBT including unusual items
-19.86M
8.20M
-15.34M
-19.91M
EBT excluding unusual items
-20.04M
-19.02M
-16.60M
-19.91M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-19.86M
8.20M
-15.34M
-19.91M
Net profit margin
-
2,337.32%
-3,501.14%
-5,562.29%
Earnings per share
-2.27
0.94
-1.76
-2.08
Interest and investment income
546.00K
618.00K
445.00K
325.00K
Interest expense
-
-
-
-
Net interest expenses
546.00K
618.00K
445.00K
325.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-23.82M
-21.43M
-18.42M
-20.13M
Gain or loss from assets sale
-
-
-192.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer